1.Medical Institution's Multiple Role in the Collaborative Innovation Transformation Mode of "Industry-University-Research-Medicine" on Domestic Surgical Robots.
Zhiqun SHU ; Jialu QU ; Shuxian ZHANG ; Yirou TIE ; Yuan CHE ; Junting LI ; Letong JIANG ; Huiqing SHEN
Chinese Journal of Medical Instrumentation 2023;47(5):582-586
In recent years, with the rapid development of Chinese domestic surgical robot technology and the expansion of the application market, the "industry-university-research-medicine" collaborative innovation transformation mode has gradually developed and formed. Medical institutions play an important role in multi-party cooperation with enterprises, universities, and research institutes, as well as in product planning, technology research and development, achievement transformation, and personnel training. On the basis of reviewing the current situation of the development of the "industry-university-research-medicine" collaborative innovation transformation mode of domestic surgical robots, this study explores the multiple roles played by medical institutions in this mode and challenges, further putting forward corresponding recommendations.
Humans
;
Robotics
;
Universities
;
Medicine
;
Industry
;
Technology
2.Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer.
Haiyang ZHANG ; Jingjing DUAN ; Yanjun QU ; Ting DENG ; Rui LIU ; Le ZHANG ; Ming BAI ; Jialu LI ; Tao NING ; Shaohua GE ; Xia WANG ; Zhenzhen WANG ; Qian FAN ; Hongli LI ; Guoguang YING ; Dingzhi HUANG ; Yi BA
Protein & Cell 2016;7(2):141-151
Gastric cancer is one of the most common malignancies worldwide; however, the molecular mechanism in tumorigenesis still needs exploration. BCL2L11 belongs to the BCL-2 family, and acts as a central regulator of the intrinsic apoptotic cascade and mediates cell apoptosis. Although miRNAs have been reported to be involved in each stage of cancer development, the role of miR-24 in GC has not been reported yet. In the present study, miR-24 was found to be up-regulated while the expression of BCL2L11 was inhibited in tumor tissues of GC. Studies from both in vitro and in vivo shown that miR-24 regulates BCL2L11 expression by directly binding with 3'UTR of mRNA, thus promoting cell growth, migration while inhibiting cell apoptosis. Therefore, miR-24 is a novel onco-miRNA that can be potential drug targets for future clinical use.
Animals
;
Apoptosis
;
genetics
;
Apoptosis Regulatory Proteins
;
deficiency
;
genetics
;
Base Sequence
;
Bcl-2-Like Protein 11
;
Cell Line, Tumor
;
Cell Movement
;
genetics
;
Cell Proliferation
;
genetics
;
Down-Regulation
;
genetics
;
Gene Silencing
;
Male
;
Membrane Proteins
;
deficiency
;
genetics
;
Mice
;
MicroRNAs
;
genetics
;
Proto-Oncogene Proteins
;
deficiency
;
genetics
;
Rats
;
Stomach Neoplasms
;
genetics
;
pathology